Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1984 Jul;326(4):313-6.
doi: 10.1007/BF00501435.

Clonidine inhibits salivary secretion by activation of postsynaptic alpha 2-receptors

Clonidine inhibits salivary secretion by activation of postsynaptic alpha 2-receptors

M D Kaniucki et al. Naunyn Schmiedebergs Arch Pharmacol. 1984 Jul.

Abstract

The effects of clonidine on the submaxillary gland of the rat were studied. Doses ranging between 100 to 3.000 micrograms/kg produced a sustained secretory response which was blocked by 0.1 mg/kg of prazosin but not by 1 mg/kg of yohimbine. Clonidine 10 micrograms/kg markedly inhibited the salivation induced by noradrenaline, methacholine and substance P but not that induced by isoproterenol. The inhibition caused by the alpha 2-agonist was greater for noradrenaline than for either methacholine or substance P. Blockade of alpha 2 adrenoceptors with yohimbine (0.3 - 1 mg/kg) prevented the inhibition by clonidine of noradrenaline, methacholine and substance P induced salivation. On the other hand, prazosin 0.1 mg/kg did not modify the inhibition by clonidine of methacholine induced secretion. The results obtained indicate that clonidine exerts a dual effect on salivary secretion: at high doses it elicits salivation through activation of alpha 1-adrenoceptors; at the dose of 10 micrograms/kg clonidine activates alpha 2-adrenoceptors which inhibit the secretory response evoked through either muscarine, substance P and alpha 1-adrenoceptor agonists.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Am J Cardiol. 1971 Jul;28(1):74-83 - PubMed
    1. J Physiol. 1981 Mar;312:297-334 - PubMed
    1. J Pharmacol Exp Ther. 1984 Apr;229(1):261-6 - PubMed
    1. J Pharmacol Exp Ther. 1979 Nov;211(2):394-400 - PubMed
    1. Naunyn Schmiedebergs Arch Pharmacol. 1975;289(3):257-74 - PubMed

Publication types